Wang Y, Cai X Y, Sheng W B
Department of Spine Surgery, the First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, China.
Zhonghua Wai Ke Za Zhi. 2024 Sep 1;62(9):887-892. doi: 10.3760/cma.j.cn112139-20240218-00072.
The traditional treatment of intervertebral disc degeneration (IVDD) mainly focuses on symptomatic treatment, and cannot restore the physiological structure and function of the intervertebral disc. Therefore, more and more scholars begin to pay attention to the application of regenerative medicine and its derived therapeutic methods in IVDD. From the histological perspective, the early stage of IVDD shows the imbalance between synthesis and catabolism, but the cell number and tissue structure are relatively complete, and the intervention of exogenous molecules or gene therapy can achieve extracellular matrix (ECM) regeneration. With the progress of IVDD, the replenishment of healthy cells is the key to treatment. In the final stage, the cell number and tissue structure are disordered. Biological materials with certain mechanical strength and cell load can be used to supplement ECM and healthy cells to realize the repair and regeneration of IVDD. Molecular, cell and gene therapy, combined with the application of new biomaterials, the treatment of IVDD is more inclined to compensate for the shortcomings through a combination approach in the future, in order to achieve the purpose of repair and regeneration.
椎间盘退变(IVDD)的传统治疗主要侧重于对症治疗,无法恢复椎间盘的生理结构和功能。因此,越来越多的学者开始关注再生医学及其衍生治疗方法在IVDD中的应用。从组织学角度来看,IVDD早期表现为合成与分解代谢失衡,但细胞数量和组织结构相对完整,外源性分子干预或基因治疗可实现细胞外基质(ECM)再生。随着IVDD进展,补充健康细胞是治疗关键。在终末期,细胞数量和组织结构紊乱。可使用具有一定机械强度和细胞负载能力的生物材料来补充ECM和健康细胞,以实现IVDD的修复与再生。分子、细胞和基因治疗,结合新型生物材料的应用,未来IVDD的治疗更倾向于通过联合方法弥补不足,以达到修复和再生的目的。